GlassScriptPhysician profile
Julian Dachille
NPI 1013170497
$4,952.29
in general payments reported to CMS, 2019-2025
11 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,793 · 2020: $139 · 2021: $44.74 · 2024: $102 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405 · Travel and Lodging: $396 · Long Term Medical Supply Or Device Loan: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.62 |
| Travel and Lodging | $395.58 |
| Long Term Medical Supply Or Device Loan | $175.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,615.61 | 2019 | |
| Sonex Health, INC. | $684.91 | 2024-2025 | Sx-One Microknife |
| Integra Lifesciences Corporation | $291.40 | 2020-2025 | Cytal, Micromatrix, Integra |
| Kairos Surgical INC | $138.45 | 2019 | |
| Acumed LLC | $58.57 | 2019-2020 | |
| Endo USA, INC. | $42.45 | 2024-2025 | Xiaflex |
| Musculoskeletal Transplant Foundation INC. | $39.43 | 2020 | |
| Endo Pharmaceuticals INC. | $37.35 | 2019-2024 | Xiaflex |
| Revance Therapeutics, INC. | $16.47 | 2025 | Daxxify |
| Avita Medical Americas, LLC | $16.25 | 2024 | |
| Kci USA, INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julian Dachille listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.